OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions

le said.

What is being done about this today? Currently marketed antidiarrheal drugs are not safe for use in young children, and there are no approved drugs for children with diarrhea. Most therapies today target the adult travelers' market with little consideration for pediatric use. Some vaccines focus on one pathogen, such as rotavirus, although there are multiple causative pathogens.

Efforts are also underway to prevent exposure to the pathogens responsible for diarrhea in developing countries. However, these require massive improvements in sanitation, hygiene, and nutritional status in developing countries, which are unlikely to have an impact in the short term.

In response, OneWorld Health is pursuing safe, effective, and affordable drug candidates for pediatric diarrhea that will reduce stool output and save babies' lives. A new drug may be used in conjunction with oral rehydration therapy (ORT) in the developing world. ORT is the globally approved treatment for secretory (watery) diarrhea that has been credited with reducing infant mortality by about half. ORT involves giving a dilute solution of sugar and salt orally to children to replace both the water and vital nutrients (electrolytes) lost in diarrhea; it does not treat the diarrhea itself. Parents, out of frustration that ORT does not reduce stool output, purchase antibiotics for their children, which are almost always ineffective and disturb normal intestinal balance.


Contact: Joanne Hasegawa
Institute for OneWorld Health

Page: 1 2

Related biology news :

1. Institute for OneWorld Health nominated for the 2004 World Technology Awards
2. Institute for OneWorld Health receives Gates Foundation grant
3. OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO
4. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
5. OneWorld Health completes enrollment, treatment in Phase III India trial
6. Institute for OneWorld Health CEO advocates focus first on developing world markets
7. OneWorld Health plans to form network of volunteer pharmaceutical scientists for global health
8. UC Santa Barbara donates discovery to OneWorld Health that may speed disease treatment
9. Victoria Hale of Institute for OneWorld Health Named Fellow by International Womens Forum
10. Health of worlds sea lions the focus of Wakefield Symposium
11. Healthy fats and oils essential to satisfy calorie-conscious consumers

Post Your Comments:

(Date:5/8/2019)... ... May 07, 2019 , ... ... been accepted into Forbes Technology Council, an invitation-only community for world-class CIOs, ... is a full-service biopharmaceutical cold chain engineering firm that guarantees confidence in ...
(Date:5/7/2019)... LONDON (PRWEB) , ... May 07, 2019 , ... ... the world’s first on-site Legionella DNA test in the UK. , In May, ... accurate qPCR Legionella results in 45 minutes, enabling operators to take corrective action ...
(Date:5/2/2019)... ... May 01, 2019 , ... uBiome, ... appointed John Rakow, the Company’s General Counsel, as Interim Chief Executive Officer of ... are currently on administrative leave. There will also be an independent investigation into ...
Breaking Biology News(10 mins):
(Date:5/4/2019)... ... May 03, 2019 , ... ... of the Dakila Pesquisas Association, the scientist and ufologist Urandir Fernandes de Oliveira, ... (DF). Urandir detailed the results of some research carried out by the association, ...
(Date:5/2/2019)... ... May 02, 2019 , ... Stay on top of current ... and food industries. Access to all webinars is free, so be sure to register ... field! , Visit http://www.xtalks.com to see our upcoming webinars: , CLINICAL TRIALS ...
(Date:4/25/2019)... FRANCISCO (PRWEB) , ... April 24, 2019 , ... ... Intelligent Virtual Agents for sales and service organizations, today announced global availability ... center software providers and enterprises of all sizes to harness the power of ...
(Date:4/15/2019)... ... April 15, 2019 , ... Sirrus, Inc., ... $2 million bench plant expansion to increase production of methylene malonate monomers and ... and construction of Sirrus’ full-scale production facility, which is scheduled to break ground ...
Breaking Biology Technology:
Cached News: